Published in Front Biosci on September 15, 1999
A myosin II ATPase inhibitor reduces force production, glucose transport, and phosphorylation of AMPK and TBC1D1 in electrically stimulated rat skeletal muscle. Am J Physiol Endocrinol Metab (2009) 1.59
The energy hypothesis of sleep revisited. Prog Neurobiol (2008) 1.47
Evidence for the location of the allosteric activation switch in the multisubunit phosphorylase kinase complex from mass spectrometric identification of chemically crosslinked peptides. J Mol Biol (2006) 1.07
Calmodulin binding to M-type K+ channels assayed by TIRF/FRET in living cells. J Physiol (2008) 1.06
Ca2+-induced structural changes in phosphorylase kinase detected by small-angle X-ray scattering. Protein Sci (2005) 1.02
Cryoelectron microscopy reveals new features in the three-dimensional structure of phosphorylase kinase. Protein Sci (2005) 0.97
PGC-1α induces mitochondrial and myokine transcriptional programs and lipid droplet and glycogen accumulation in cultured human skeletal muscle cells. PLoS One (2012) 0.93
KIAA1199 interacts with glycogen phosphorylase kinase β-subunit (PHKB) to promote glycogen breakdown and cancer cell survival. Oncotarget (2014) 0.93
The structure of phosphorylase kinase holoenzyme at 9.9 angstroms resolution and location of the catalytic subunit and the substrate glycogen phosphorylase. Structure (2009) 0.91
In Silico characterization of phosphorylase kinase: evidence for an alternate intronic polyadenylation site in PHKG1. Mol Genet Metab (2007) 0.90
Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A (2016) 0.90
Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene. Mol Genet Metab (2013) 0.87
Glucoamylase-like domains in the alpha- and beta-subunits of phosphorylase kinase. Protein Sci (2003) 0.87
Structural evidence for co-evolution of the regulation of contraction and energy production in skeletal muscle. J Mol Biol (2008) 0.86
Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. J Proteome Res (2014) 0.85
Identification of novel ryanodine receptor 1 (RyR1) protein interaction with calcium homeostasis endoplasmic reticulum protein (CHERP). J Biol Chem (2011) 0.84
Clinical, Biochemical, and Genetic Characterization of Glycogen Storage Type IX in a Child with Asymptomatic Hepatomegaly. Pediatr Gastroenterol Hepatol Nutr (2015) 0.83
Mass spectrometry reveals differences in stability and subunit interactions between activated and nonactivated conformers of the (αβγδ)4 phosphorylase kinase complex. Mol Cell Proteomics (2012) 0.82
Purification of tropomyosin, paramyosin, actin, tubulin, troponin and kinases for chemiproteomics and its application to different scientific fields. PLoS One (2011) 0.81
Glycogen synthesis correlates with androgen-dependent growth arrest in prostate cancer. BMC Urol (2005) 0.81
Nrf2-Mediated Regulation of Skeletal Muscle Glycogen Metabolism. Mol Cell Biol (2016) 0.80
Structure and location of the regulatory β subunits in the (αβγδ)4 phosphorylase kinase complex. J Biol Chem (2012) 0.80
Single molecule analyses of the conformational substates of calmodulin bound to the phosphorylase kinase complex. Protein Sci (2007) 0.80
The regulatory beta subunit of phosphorylase kinase interacts with glyceraldehyde-3-phosphate dehydrogenase. Biochemistry (2008) 0.80
Dynamics of intra-follicular glucose during luteinization of macaque ovarian follicles. Mol Cell Endocrinol (2010) 0.80
Physicochemical changes in phosphorylase kinase associated with its activation. Protein Sci (2008) 0.79
Trans-10, cis-12-conjugated linoleic acid alters hepatic gene expression in a polygenic obese line of mice displaying hepatic lipidosis. J Nutr Biochem (2009) 0.78
Regulatory mechanisms for glycogenolysis and K+ uptake in brain astrocytes. Neurochem Int (2013) 0.78
Acute and chronic changes in glycogen phosphorylase in hippocampus and entorhinal cortex after status epilepticus in the adult male rat. Eur J Neurosci (2007) 0.78
Expressed phosphorylase b kinase and its alphagammadelta subcomplex as regulatory models for the rabbit skeletal muscle holoenzyme. Biochemistry (2009) 0.78
Physicochemical changes in phosphorylase kinase induced by its cationic activator Mg(2+). Protein Sci (2013) 0.77
The glucoamylase inhibitor acarbose is a direct activator of phosphorylase kinase. Biochemistry (2010) 0.77
A review of methods used for identifying structural changes in a large protein complex. Methods Mol Biol (2012) 0.77
Functional impact of glycogen degradation on astrocytic signalling. Biochem Soc Trans (2014) 0.76
PHKA2 mutation spectrum in Korean patients with glycogen storage disease type IX: prevalence of deletion mutations. BMC Med Genet (2016) 0.75
The regulatory α and β subunits of phosphorylase kinase directly interact with its substrate, glycogen phosphorylase. Biochem Biophys Res Commun (2016) 0.75
Phosphorylase kinase β affects colorectal cancer cell growth and represents a novel prognostic biomarker. J Cancer Res Clin Oncol (2017) 0.75
An adenosine 3',5'-monophosphate-dependant protein kinase from rabbit skeletal muscle. J Biol Chem (1968) 8.62
Krebs EG: Purification and characterization of a protein inhibitor of adenosine 3',5'-monophosphate-dependent protein kinases. J Biol Chem (1971) 4.41
A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J Biol Chem (1986) 3.49
Purification and properties of rabbit skeletal muscle adenosine 3',5'-monophosphate-dependent protein kinases. J Biol Chem (1971) 3.18
The genome of Salinibacter ruber: convergence and gene exchange among hyperhalophilic bacteria and archaea. Proc Natl Acad Sci U S A (2005) 2.43
Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) (2004) 2.33
Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum (2003) 2.15
Characterization of the interaction of a protein inhibitor with adenosine 3',5'-monophosphate-dependent protein kinases. I. Interaction with the catalytic subunit of the protein kinase. J Biol Chem (1972) 2.13
Purification and properties of chicken liver D-3-phosphoglycerate dehydrogenase. Biochemistry (1965) 2.08
Effects of pulsed ultrasound and temperature on the development of rat embryos in culture. Teratology (1990) 2.07
Catlysis of the phosphrylaseinase actition reaction. J Biol Chem (1971) 1.89
Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein. J Biol Chem (1989) 1.89
Quantitative sensory testing in painful osteoarthritis: a systematic review and meta-analysis. Osteoarthritis Cartilage (2012) 1.74
Measurement of cyclic 3',5'-denosine monophosphate by the activation of skeletal muscle protein kinase. J Biol Chem (1971) 1.72
The catalytic subunit of cAMP-dependent protein kinase induces expression of genes containing cAMP-responsive enhancer elements. Nature (1988) 1.66
Studies on the kinetic mechanism of the catalytic subunit of the cAMP-dependent protein kinase. J Biol Chem (1983) 1.61
Inactivation of glycogen synthetase and activation of phosphorylase kinase by muscle adenosine 3',5'-monophosphate-dependent protein kinases. J Biol Chem (1970) 1.57
Phosphorylation of Avena phytochrome in vitro as a probe of light-induced conformational changes. J Biol Chem (1986) 1.53
A cyclic 3',5'-amp-stimulated protein kinase from cardiac muscle. Adv Enzyme Regul (1970) 1.44
Mg X ATP2-dependent interaction of the inhibitor protein of the cAMP-dependent protein kinase with the catalytic subunit. J Biol Chem (1983) 1.43
Comparative studies on the pathways for serine biosynthesis in animal tissues. J Biol Chem (1966) 1.40
A rapid method for the measurement of [gamma-32P]ATP specific radioactivity in tissue extracts and its application to the study of 32Pi uptake in perfused rat heart. Anal Biochem (1976) 1.37
Activation of adipose tissue lipase by skeletal muscle cyclic adenosine 3',5'- monophosphate-stimulated protein kinase. J Biol Chem (1970) 1.36
Multiple forms of hepatic adenosine 3':5'-monophosphate dependent protein kinase. Biochemistry (1971) 1.35
Protein kinase inhibitor-(6-22)-amide peptide analogs with standard and nonstandard amino acid substitutions for phenylalanine 10. Inhibition of cAMP-dependent protein kinase. J Biol Chem (1989) 1.32
Characterization of the interaction of a protein inhibitor with adenosine 3',5'-monophosphate-dependent protein kinases. II. Mechanism of action with the holoenzyme. J Biol Chem (1973) 1.32
Possibility of shape conformers of the protein inhibitor of the cyclic adenosine monophosphate dependent protein kinase. Biochemistry (1979) 1.24
An active twenty-amino-acid-residue peptide derived from the inhibitor protein of the cyclic AMP-dependent protein kinase. Biochem J (1985) 1.21
The elementary reactions of the pig heart pyruvate dehydrogenase complex. A study of the inhibition by phosphorylation. Biochem J (1976) 1.21
Detection of methicillin-resistant Staphylococcus aureus by microdilution and disk elution susceptibility systems. J Clin Microbiol (1984) 1.20
Angiogenesis in two animal models of osteoarthritis. Osteoarthritis Cartilage (2007) 1.18
The interrelationship between cAMP-dependent alpha and beta subunit phosphorylation in the regulation of phosphorylase kinase activity. Studies using subunit specific phosphatases. J Biol Chem (1987) 1.17
Differential and common recognition of the catalytic sites of the cGMP-dependent and cAMP-dependent protein kinases by inhibitory peptides derived from the heat-stable inhibitor protein. J Biol Chem (1986) 1.16
Some teratogenic properties of ethanol and acetaldehyde in C57BL/6J mice: implications for the study of the fetal alcohol syndrome. Teratology (1983) 1.15
Protein kinases: aspects of their regulation and diversity. Recent Prog Horm Res (1973) 1.14
Lengthy incubation for homosexual transmission of acquired immunodeficiency syndrome in a 79 year old man. Postgrad Med J (1989) 1.10
Effects of a metalloproteinase inhibitor on osteochondral angiogenesis, chondropathy and pain behavior in a rat model of osteoarthritis. Osteoarthritis Cartilage (2010) 1.08
Monoarthritis in the rat knee induces bilateral and time-dependent changes in substance P and calcitonin gene-related peptide immunoreactivity in the spinal cord. Neuroscience (1993) 1.07
Physiochemical properties of rabbit skeletal muscle phosphorylase kinase. Biochemistry (1973) 1.07
The alpha- and beta-isoforms of the inhibitor protein of the 3',5'-cyclic adenosine monophosphate-dependent protein kinase: characteristics and tissue- and developmental-specific expression. Mol Endocrinol (1992) 1.04
Circular dichroic evidence for an ordered sequence of ligand/binding site interactions in the catalytic reaction of the cAMP-dependent protein kinase. Biochemistry (1985) 1.04
Subunit phosphorylation and activation of skeletal muscle phosphorylase kinase by the cAMP-dependent protein kinase. Divalent metal ion, ATP, and protein concentration dependence. J Biol Chem (1985) 1.04
Molecular cloning of a rat testis form of the inhibitor protein of cAMP-dependent protein kinase. Proc Natl Acad Sci U S A (1991) 1.03
Effect of three animal models of inflammation on nerve fibres in the synovium. Ann Rheum Dis (1994) 1.03
Nuclear protein kinase activity in glucagon-stimulated perfused rat livers. Biochem J (1974) 1.03
A fast-twitch oxidative-glycolytic muscle with a robust inward calcium current. Can J Physiol Pharmacol (1985) 1.02
Solution structure of the cAMP-dependent protein kinase catalytic subunit and its contraction upon binding the protein kinase inhibitor peptide. Biochemistry (1993) 1.02
Antiinflammatory agents. 3. Synthesis and pharmacological evaluation of 2-amino-3-benzoylphenylacetic acid and analogues. J Med Chem (1984) 1.01
Utilization of the inhibitor protein of adenosine cyclic monophosphate-dependent protein kinase, and peptides derived from it, as tools to study adenosine cyclic monophosphate-mediated cellular processes. Methods Enzymol (1991) 1.01
Autophosphorylation of the catalytic subunit of cAMP-dependent protein kinase. J Biol Chem (1992) 1.01
Peptide inhibitors of cAMP-dependent protein kinase. Methods Enzymol (1988) 1.00
Repeated allergen exposure of sensitized Brown-Norway rats induces airway cell DNA synthesis and remodelling. Eur Respir J (1999) 0.99
Nuclear protein-kinase activity in perfused rat liver stimulated with dibutyryl-adenosine cyclic 3':5'-monophosphate. Eur J Biochem (1975) 0.99
Inhibitor protein of the cAMP-dependent protein kinase: characteristics and purification. Methods Enzymol (1983) 0.99
Detecting depression in elderly medical inpatients. J Consult Clin Psychol (1988) 0.99
Critical controls in the evaluation of cAMP-dependent protein kinase activity ratios as indices of hormonal action. J Biol Chem (1980) 0.98
The inhibitor protein of the cAMP-dependent protein kinase-catalytic subunit interaction. Parameters of complex formation. J Biol Chem (1986) 0.98
Age differences in central perceptual processing: a dichoptic backward masking investigation. J Gerontol (1976) 0.98
Conformational analysis of PKI(5-22)amide, the active inhibitory fragment of the inhibitor protein of the cyclic AMP-dependent protein kinase. Biochem J (1989) 0.97
Osteochondral angiogenesis and increased protease inhibitor expression in OA. Osteoarthritis Cartilage (2009) 0.96
Heat-stable inhibitor protein derived peptide substrate analogs: phosphorylation by cAMP-dependent and cGMP-dependent protein kinases. Biochemistry (1995) 0.96
The effects of calcitonin gene-related peptide on formation of intra-articular oedema by inflammatory mediators. Br J Pharmacol (1992) 0.95
In situ regulation of cell-cell communication by the cAMP-dependent protein kinase and protein kinase C. Mol Cell Biochem (1993) 0.93
Expression in Escherichia coli and characterization of the heat-stable inhibitor of the cAMP-dependent protein kinase. J Biol Chem (1991) 0.93
Involvement of cysteinyl leukotrienes in airway smooth muscle cell DNA synthesis after repeated allergen exposure in sensitized Brown Norway rats. Br J Pharmacol (1999) 0.93
Cyclic AMP-dependent protein kinases from skeletal muscle and liver. Adv Cyclic Nucleotide Res (1972) 0.92
Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design. J Med Chem (1997) 0.92
Hyperthermia and birth defects. Reprod Toxicol (1996) 0.91
Hyperthermia, teratogenesis and the heat shock response in mammalian embryos in culture. Int J Dev Biol (1997) 0.91
Psychological dysfunction and physical health among elderly medical inpatients. J Consult Clin Psychol (1988) 0.90
Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent. J Med Chem (1999) 0.90
Fatal acute pyelonephritis following pulsed methylprednisolone for rheumatoid arthritis. Ann Rheum Dis (1990) 0.90
Circular dichroic investigations of secondary structure in synthetic peptide inhibitors of cAMP-dependent protein kinase: a model for inhibitory potential. Biochemistry (1987) 0.89
Purification and characterization of an inhibitor protein of cyclic AMP-dependent protein kinases. Methods Enzymol (1974) 0.89
Phosphorylation and dephosphorylation of phosphorylase kinase in the perfused rat heart. J Biol Chem (1979) 0.89
Quaternary structures of a catalytic subunit-regulatory subunit dimeric complex and the holoenzyme of the cAMP-dependent protein kinase by neutron contrast variation. J Biol Chem (1998) 0.89
Analysis by mutagenesis of the ATP binding site of the gamma subunit of skeletal muscle phosphorylase kinase expressed using a baculovirus system. Biochemistry (1992) 0.89
Criteria for the classification of protein kinases. Methods Enzymol (1974) 0.89
Age-related differences in two stages of central perceptual processes: the effects of short duration targets and criterion differences. J Gerontol (1979) 0.88
Characterization of multiple charge isomers of the inhibitor protein of the cyclic AMP-dependent protein kinase from bovine heart and rabbit skeletal muscle. Arch Biochem Biophys (1980) 0.88
Differences in structural and pain phenotypes in the sodium monoiodoacetate and meniscal transection models of osteoarthritis. Osteoarthritis Cartilage (2013) 0.87
Structural basis for the low affinities of yeast cAMP-dependent and mammalian cGMP-dependent protein kinases for protein kinase inhibitor peptides. Biochemistry (1992) 0.87
Solution structure of phosphorylase kinase studied using small-angle X-ray and neutron scattering. Biochemistry (1992) 0.87
High and intermediate affinity calmodulin binding domains of the alpha and beta subunits of phosphorylase kinase and their potential role in phosphorylation-dependent activation of the holoenzyme. J Biol Chem (1992) 0.87
Spatial cognition and neighborhood use: the relationship in older adults. Psychol Aging (1992) 0.86
Cyclic adenosine monophosphate dependent and independent phosphorylation of sarcolemma membrane proteins in perfused rat heart. Biochemistry (1979) 0.86
Phosphorylation and activation of the cardiac isoenzyme of phosphorylase kinase by the cAMP-dependent protein kinase. J Biol Chem (1981) 0.86
Hydrophobic benzoic acids as inhibitors of influenza neuraminidase. Bioorg Med Chem (1999) 0.86
The effect of practice on age differences in central perceptual processing. J Gerontol (1976) 0.86
Role of the cAMP-dependent protein kinase as the transducer of cAMP action. Biochem Pharmacol (1978) 0.86
Rasch analysis of the intermittent and constant osteoarthritis pain (ICOAP) scale. Osteoarthritis Cartilage (2012) 0.85
Purification and properties of the cardiac isoenzyme of phosphorylase kinase. J Biol Chem (1980) 0.85
Characterization of the isolated rat flexor digitorum brevis for the study of skeletal muscle phosphorylase kinase phosphorylation. J Biol Chem (1987) 0.85
Guanidinobenzoic acid inhibitors of influenza virus neuraminidase. J Mol Biol (1997) 0.85
Characteristics of the adenohypophyseal Ca2+-phospholipid-dependent protein kinase. Mol Cell Endocrinol (1984) 0.85
Tyrosine kinase catalyzed phosphorylation and inactivation of the inhibitor protein of the cAMP-dependent protein kinase. J Biol Chem (1987) 0.85
Colon carcinoma and diabetes mellitus. Cancer (1984) 0.84
Influence of HbS levels upon the hematological and clinical characteristics of sickle cell trait. Am J Hematol (1986) 0.84
Multiplicity of the beta form of the cAMP-dependent protein kinase inhibitor protein generated by post-translational modification and alternate translational initiation. J Biol Chem (1997) 0.83